Clinical Trial Update: The Study of Ciprofol for the Suppression of Cardiovascular Responses to Tracheal Intubation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ciprofol for suppressing cardiovascular responses during tracheal intubation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intubation-related Cardiovascular Response Suppression

Drugs mentioned

• Ciprofol (ciprofol)

Snippet

Sponsor: The Second Affiliated Hospital of Hainan Medical University | Conditions: Intubation, Intratracheal, Adverse Effects | Phase 4 | Status: UNKNOWN